Rafferty Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-53,201
| Closed | -$151K | – | 1170 |
|
|
2024
Q1 | $151K | Buy |
53,201
+34,881
| +190% | +$99.1K | ﹤0.01% | 1068 |
|
|
2023
Q4 | $270K | Buy |
18,320
+7,028
| +62% | +$103K | ﹤0.01% | 1041 |
|
|
2023
Q3 | $207K | Buy |
+11,292
| New | +$207K | ﹤0.01% | 1052 |
|
|
2023
Q1 | – | Sell |
-6,298
| Closed | -$233K | – | 1142 |
|
|
2022
Q4 | $233K | Buy |
+6,298
| New | +$233K | ﹤0.01% | 1055 |
|